
Mediclave Pharmaceuticals Private Limited
Founded in 2014 and headquartered in Maharashtra, India.
Founded in 2014 and headquartered in Maharashtra, India.
Thane, Maharashtra, India
+91-XXXXXXXXXX
-
U24233MH2014PTC255944
255944
Private Limited Indian Non-Government Company
09 Jul 2014
21 Aug 2019
31 Mar 2019
Unlisted
Roc Mumbai
Name | Designation | Appointment Date | Status |
---|---|---|---|
Ketan Desai ![]() | Director | 09-Jul-2014 | Current |
Satyen Shah ![]() | Director | 09-Jul-2014 | Current |
Mediclave Pharmaceuticals Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
In 2017, Mediclave Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Mediclave Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Mediclave Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mediclave Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Mediclave Pharmaceuticals Private Limited last Annual general meeting of members was held on 21 Aug 2019 as per latest MCA records.
Mediclave Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Mumbai.
Ketan Jayant Desai was appointed as a Director was appointed as a Director on 09 Jul 2014 & has been associated with this company since 10 years 7 months .
Satyen Pratap Shah was appointed as a Director was appointed as a Director on 09 Jul 2014 & has been associated with this company since 10 years 7 months .
Mediclave Pharmaceuticals Private Limited was registered on 09 Jul 2014 with Roc Mumbai & aged 10 years 7 months as per MCA records.
Mediclave Pharmaceuticals Private Limited was incorporated on 09 Jul 2014.
The authorized share capital of Mediclave Pharmaceuticals Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.
Currently 2 directors are associated with Mediclave Pharmaceuticals Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Mediclave Pharmaceuticals Private Limited is Flat No. 11 Wing 22B Brindavan Vaibhav N.G Marg, Brindaban India, Thane, Maharashtra, 400601.
The corporate identification number (CIN) of Mediclave Pharmaceuticals Private Limited is U24233MH2014PTC255944 and the company number is 255944 as per Ministry of Corporate Affairs (MCA).
The most recent Balance Sheet for Mediclave Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2019.
OK
JM